Science Explorer Back to mapMap

Most cited papers from Astrimmune (United Kingdom)

What are the most cited papers from Astrimmune (United Kingdom)?

The most cited paper from Astrimmune (United Kingdom) is "Audit of the autoantibody test, EarlyCDT®-Lung, in 1600 patients: An evaluation of its performance in routine clinical practice" (James R. Jett, Laura J. Peek, Lynn Fredericks et al., 2013), with 244 citations. Next come "Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer" (104) and "Cost-effectiveness of an autoantibody test (EarlyCDT-Lung) as an aid to early diagnosis of lung cancer in patients with incidentally detected pulmonary nodules" (41).

Showing 18 of 18 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Audit of the autoantibody test, EarlyCDT®-Lung, in 1600 patients: An evaluation of its performance in routine clinical practice James R. Jett, Laura J. Peek, Lynn Fredericks et al. · Lung Cancer Open access 22 Oct 2013 244
2 Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer Pierre Pascal Massion, Graham F. Healey, Laura J. Peek et al. · Journal of Thoracic Oncology Open access 12 Sep 2016 104
3 Cost-effectiveness of an autoantibody test (EarlyCDT-Lung) as an aid to early diagnosis of lung cancer in patients with incidentally detected pulmonary nodules John Edelsberg, Derek A. Weycker, Mark Atwood et al. · PLoS ONE Open access 22 May 2018 41
4 A Structural Model for the Generation of Continuous Curvature on the Surface of a Retroviral Capsid Graham D. Bailey, Jaekyung Hyun, ALOK KUMAR MITRA et al. · Journal of Molecular Biology 30 Jan 2012 36
5 Use of autoantibodies in breast cancer screening and diagnosis Sarah J. Storr, Jayeta Chakrabarti, Anthony C. Barnes et al. · Expert Review of Anticancer Therapy Open access Aug 2006 32
6 Serum Autoantibody Measurement for the Detection of Hepatocellular Carcinoma Catrin H. Middleton, William Lucien Irving, John F. R. Robertson et al. · PLoS ONE Open access 5 Aug 2014 23
7 The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders Paul Maddison, Maarten J. Titulaer, Jan J.G.M. Verschuuren et al. · Journal of Neuroimmunology Open access 8 Nov 2018 15
8 Early immune factors associated with the development of post-acute sequelae of SARS-CoV-2 infection in hospitalized and non-hospitalized individuals Jacqueline M. Leung et al. · Frontiers in Immunology Open access 22 Jan 2024 13
9 Neuronal antibody detection and improved lung cancer prediction in Lambert-Eaton myasthenic syndrome Paul Maddison, Paul Gozzard, Girija Sadalage et al. · Journal of Neuroimmunology 10 Jan 2020 11
10 Effect of a Rule-in Biomarker Test on Pulmonary Nodule Management: A Survey of Pulmonologists and Thoracic Surgeons Nichole T. Tanner, Paul Bradley Brasher, James R. Jett et al. · Clinical Lung Cancer 12 Jun 2019 11
11 Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinoma Christopher Welberry, Isabel K. Macdonald, Jane McElveen et al. · PLoS ONE Open access 6 May 2020 10
12 Using Automated Image Analysis Algorithms to Distinguish Normal, Aberrant, and Degenerate Mitotic Figures Induced by Eg5 Inhibition Alison L. Bigley, Stéphanie Klein, Barry R. Davies et al. · Toxicologic Pathology Open access 2 Mar 2016 5
13 Cost-Effectiveness Analysis of Baseline Testing for Resistance-Associated Polymorphisms to Optimize Treatment Outcome in Genotype 1 Noncirrhotic Treatment-Naïve Patients With Chronic Hepatitis C Virus Christopher G. Fawsitt et al. · Value in Health Open access 24 Oct 2019 2
14 The Additive Effect of the Stratified EarlyCDT®-Lung Serum Autoantibody Test on the Assessment of Lung Cancer Risk Graham F. Healey, Laura J. Peek, Lynn Fredericks et al. · CHEST Journal Oct 2012 2
15 P2.11-10 Potential Utility of a Positive EarlyCDT®-Lung Blood Biomarker Test in Indeterminate Pulmonary Nodules James R. Jett, Graham F. Healey, Anne Murray et al. · Journal of Thoracic Oncology Open access Oct 2018 1
16 P1.03-007 Improvement in Performance of an Autoantibody Panel Test for Detection of Lung Cancer by Addition of a Single Novel Biomarker (EDB1) Caroline J Chapman, Jane McElveen, Jared Allen et al. · Journal of Thoracic Oncology Open access 2017 1
17 Fluorescent capillary fill device: a quantitative whole-blood assay system suited to point-of-care use Phelim B. Daniels, J. Philip Vessey, Janys E. Fletcher et al. · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE Conference paper 10 Apr 1998 1
18 Reproducibility of Autoantibody Measurements in Normal Individuals Using the Early CDT-Lung Test Andrea D. Murray, Graham F. Healey, Caroline J Chapman et al. · CHEST Journal Oct 2010 1

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.